04.03.2015 • News

Burkhard Quellenberg is new Global Director HR at Oxea

Burkhard Quellenberg (47) is Oxea's new Global Director Human Resources.

Burkhard Quellenberg is Oxeas new Global Director Human Resources
Burkhard Quellenberg is Oxea's new Global Director Human Resources

His previous career has included management positions at IT multinational Bull and mechanical engineers Manitowoc Germany. An occupational and organizational psychologist by trade, Quellenberg held a number of positions at SABIC Europe, most recently HR Director Business & Functions Europe, before moving to Oxea.

Strategically, Quellenberg prioritizes human resource development: "Over the last few years, Oxea has been recognized time and again as an exceptionally employee-focused business. I see that as our brief for the future: we will use systematic training and human resource development to become even better adapted to the challenges of demographic change. As an attractive employer, we will also continue to promote programs that help our employees stay fit and healthy," continues Quellenberg.

Employing over 1,400 people, Oxea is one of the world's key producers of oxo chemicals, which are used internationally by industrial manufacturers to create products such as phthalate-free plastics, high-quality coatings and energy-efficient lubricants, as well as cosmetic and pharmaceutical goods.

Company

Logo:

Oxea

Rheinpromenade 4a
40789 Monheim am Rhein
Germany

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read